Lilly vs Pfizer: Obesity Race Reaches Market Highs
Lilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Which Is Better Target Date Funds Or Age Based Strategy: Brief. A quick look at the trade-offs between these approaches to help you decide what suits you.
27,345 articlesLilly leads the GLP-1 obesity wave as Pfizer rebuilds with deals and repurposed assets. Q1 2026 results underscore tw...
Investors are watching a handful of tech names retreat despite strong long term potential. This guide explains how be...
Regulators and banks frame XRP's path as traders debate a remote target. This report lays out what would be required ...
A renowned artist and philanthropist reveals a different dream: winemaking. This article turns that tale into practic...
Retirees are dialing in on steady monthly income. Here are five dependable dividend pay stocks that aim to deliver re...
A patient investment fund quietly grabbed a multi-million stake in Masimo after a landmark deal. This article breaks ...
Despite the everyday label of 'dull,' transportation stocks move goods and markets. In 2026, two names shine with str...
This article breaks down calumet (clmt) 2026 earnings into actionable insights. Learn how to read the Q1 transcript, ...
AI headlines sent IT-services stocks lower, but is the pullback justified? This guide explains what drives the move, ...
Workday delivered a stronger-than-expected earnings beat, but the market fixated on AI-driven demand shifts that coul...
SpaceX's Starlink is no longer just a satellite internet service. As Oppenheimer analysts suggest, it could upend a $...
Carl Icahn’s latest stake move in Icahn Enterprises drew attention from investors. This article breaks down what icah...